• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Femtech Investment Round-up: July 2022

By Femtech Insider Investment, Investment Round-ups, News August 1, 2022
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Ecosystem, Endometriosis, News March 26, 2024
25% of Women Have Been Pressured Into Returning to Work Early After Health Issues, According to New Study
News, Pelvic Health, Women's Health December 13, 2022
Rejoni Raises $25M in Series B Funding for Its Hydrogel System to Prevent Intrauterine Adhesions Following Transcervical Gynecological Procedures
Recent Posts
  • Reunion Neuroscience Reports Positive Phase 2 Results for Psychedelic Postpartum Depression Treatment
  • Teal Health Launches At-Home Cervical Cancer Screening in California
  • Femasys Secures First European Order for Non-Surgical Contraceptive FemBloc
  • Ultrahuman Acquires viO HealthTech to Launch Advanced Cycle Tracking for Smart Ring
  • AbbVie Receives UK MHRA Approval for Ovarian Cancer Treatment ELAHERE

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2025. All rights reserved.